PharmaResearch Presents Aesthetic Portfolio at Busan Conference
PharmaResearch presented Rejuran and Rejubeau to regional clinicians as a gold sponsor of the 53rd Korean Society for Laser Dermatology and Trichology Busan Conference.
This article was automatically drafted and passed editorial compliance checks. It synthesizes public source metadata and is not a substitute for individual care or clinical review.
PharmaResearch joined the 53rd Korean Society for Laser Dermatology and Trichology Busan Conference held at Signiel Busan on August 30. The company used the meeting to present its aesthetic portfolio, including Rejuran and Rejubeau.
About 1,000 clinicians from Busan, Ulsan and South Gyeongsang Province attended to exchange current knowledge and clinical information in aesthetic medicine. PharmaResearch participated as a gold sponsor and operated a 12-booth event space.
What happened at the conference
PharmaResearch placed Rejuran and Rejubeau at the center of its conference presentation. Its participation connected the company’s aesthetic portfolio with a regional meeting focused on skin, laser and hair-related medical practice.
The society’s Busan conference brought together clinicians from three southeastern regions for academic exchange. PharmaResearch supported the event at the gold-sponsor level and conducted promotional activities in its large event area.
Limits and patient context
The reports describe conference participation and product presentation, not a clinical comparison or patient-outcome study. They do not establish effectiveness, side effects, recovery time or suitability for any individual treatment plan.
Anyone considering a skin laser or related aesthetic procedure should expect individual variation and consult a qualified physician about the intended procedure, alternatives, possible side effects and recovery. A conference display does not replace an examination or a treatment plan based on the patient’s condition.
Questions for a consultation
Ask which procedure is being proposed and whether the products discussed at the conference are relevant to it. Clarify the treatment goal, why that option is being considered and what alternatives fit your skin condition.
The consultation should also cover the clinician’s expected side effects, recovery guidance and factors that may affect individual variation. Patients should ask what follow-up is planned and whom to contact if an unexpected reaction occurs.
Frequently asked questions
What did PharmaResearch present at the Busan conference?
PharmaResearch presented its aesthetic portfolio, including Rejuran and Rejubeau. It participated as a gold sponsor and operated a 12-booth event space.
Who attended the Busan conference?
About 1,000 clinicians from Busan, Ulsan and South Gyeongsang Province attended. They gathered to share current knowledge and clinical information in aesthetic medicine.
Does the conference report show how these products perform for patients?
No patient-outcome comparison was reported; the event coverage focused on participation and product presentation. Consult a qualified physician for guidance on suitability, individual variation, side effects and recovery.
Questions to take to your clinician
- What exact procedure are you proposing, and what is its goal for my skin?
- Are Rejuran or Rejubeau relevant to this plan, and why?
- What side effects and individual variation should I consider?
- What recovery guidance and follow-up plan would apply to me?
- What alternatives may suit my condition and treatment goal?
MediIndex articles are for general information only and are not medical advice, diagnosis, or advertising. Outcomes vary by individual — consult a board-certified specialist for personal decisions.
